GDS Wealth Management Buys 324,798 Shares of Oscar Health, Inc. (NYSE:OSCR)

GDS Wealth Management grew its stake in Oscar Health, Inc. (NYSE:OSCR) by 1,545.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 345,817 shares of the company’s stock after acquiring an additional 324,798 shares during the period. GDS Wealth Management owned 0.14% of Oscar Health worth $4,648,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. KBC Group NV lifted its position in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after acquiring an additional 2,555 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in shares of Oscar Health in the fourth quarter worth $100,000. Optimum Investment Advisors purchased a new position in shares of Oscar Health during the third quarter worth $142,000. Aigen Investment Management LP purchased a new position in shares of Oscar Health during the third quarter worth $205,000. Finally, Rolek Wealth Management LLC acquired a new stake in Oscar Health during the fourth quarter valued at $208,000. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several analyst reports. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group initiated coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target on the stock. Finally, Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of “Hold” and a consensus target price of $21.56.

Oscar Health Price Performance

Oscar Health stock opened at $16.72 on Tuesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of -278.55, a price-to-earnings-growth ratio of 0.67 and a beta of 1.73. The company’s 50 day simple moving average is $15.22 and its 200-day simple moving average is $16.85. Oscar Health, Inc. has a 1 year low of $12.84 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same quarter last year, the firm posted ($0.29) EPS. The company’s revenue for the quarter was up 68.3% on a year-over-year basis. As a group, equities research analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Steven Wolin sold 19,580 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $354,006.40. Following the completion of the transaction, the chief operating officer now owns 102,598 shares in the company, valued at approximately $1,854,971.84. This represents a 16.03 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of Oscar Health stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now owns 5,031,262 shares in the company, valued at $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.